SIGHT SCIENCES INC. - COMMON STOCK

Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry

06 5 2023 11:30:00 提供 Nasdaq GlobeNewswire

Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023

04 5 2023 16:05:01 提供 Nasdaq GlobeNewswire

Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

01 5 2023 16:05:00 提供 Nasdaq GlobeNewswire

Sight Sciences to Present at the Upcoming Bank of America Securities 2023 Health Care Conference

26 4 2023 16:05:01 提供 Nasdaq GlobeNewswire

Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023

20 4 2023 16:05:00 提供 Nasdaq GlobeNewswire

Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023

13 4 2023 16:05:41 提供 Nasdaq GlobeNewswire

Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer

03 4 2023 16:05:00 提供 Nasdaq GlobeNewswire

Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office

30 3 2023 08:00:00 提供 Nasdaq GlobeNewswire

Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results

13 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System

09 3 2023 08:30:00 提供 Nasdaq GlobeNewswire

Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023

23 2 2023 16:05:00 提供 Nasdaq GlobeNewswire

Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference

22 2 2023 16:05:01 提供 Nasdaq GlobeNewswire

Sight Sciences Announces 1,000th TearCare® Customer Installation

26 1 2023 08:30:00 提供 Nasdaq GlobeNewswire

Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results

09 1 2023 16:20:00 提供 Nasdaq GlobeNewswire

Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months

08 12 2022 08:30:00 提供 Nasdaq GlobeNewswire

Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference

22 11 2022 08:30:00 提供 Nasdaq GlobeNewswire

Sight Sciences Reports Third Quarter 2022 Financial Results

10 11 2022 16:05:02 提供 Nasdaq GlobeNewswire

Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure

03 11 2022 08:30:01 提供 Nasdaq GlobeNewswire

Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022

20 10 2022 17:20:54 提供 Nasdaq GlobeNewswire

Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED)

29 9 2022 08:30:00 提供 Nasdaq GlobeNewswire